BPCA Collaborative Efforts
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) strives to gain input from experts in academia, the government, and industry through different activities and during various stages in a drug study.
The following list represents ongoing and previous activities sponsored by the Obstetric and Pediatric Pharmacology Branch (OPPB) in support of the Best Pharmaceuticals in Children Act (BPCA). Please feel free to contact OPPB staff if you are interested in learning more about these activities.
Meetings
2012 2011 2009 2008 2007 2006 2005 2004
2012
2012 Meeting of the T32 Trainees
September 13-14, 2012
Executive Plaza North, Rockville, MD
Meeting Minutes for 2012 Meeting of the T32 Trainees (PDF 564 kb)
2012 Workshop on Advancing Pediatric Therapeutics
April 29, 2012
Boston Marriott Copley Place, Boston, MA
Meeting Minutes for 2012 Workshop on Advancing Pediatric Therapeutics (PDF 125 kb)
top of page
2011
Pediatric Formulations Initiative (PFI) Workshop
November 1-2, 2011
Bolger Center, Potomac, MD
Meeting Minutes for Pediatric Formulation Initiative (PFI) Workshop November 2011 (PDF 473 kb)
top of page
2009
Workshop on Ethical and Regulatory Issues in Global Pediatric Trials
September 20–22, 2009
The Legacy Meeting Centre, Rockville, MD
Meeting Minutes for Workshop on Ethical and Regulatory Issues in Global Pediatric Trials September 2009 (PDF 325 kb)
Breakout Group A Summary (PDF 151 kb)
Breakout Group B Summary (PDF 166 kb)
Breakout Group C Summary (PDF 176 kb)
Breakout Group D Summary (PDF 140 kb)
BPCA Workshop: Pharmacogenomics (PGx) - A Path to Individualized Medicine for Pediatrics
April 21–22, 2009
Neuroscience Center, Rockville, MD
Meeting Minutes for Pharmacogenomics (PGx) April 2009 (PDF 246 kb)
top of page
2008
Hepatic Toxicity Following Treatment for Pediatric Graves’ Disease Meeting
October 28, 2008
6100 Executive Boulevard, Rockville, MD
Meeting Minutes for Hepatic Toxicity Following Treatment for Pediatric Graves’ Disease Meeting October 2008 (PDF 1.66 mb)
2008 BPCA Biodefense Meeting
September 8–9, 2008
EPN Conference Center, Rockville, MD
Meeting Minutes for Biodefense Meeting September 2008 (PDF 2.62 mb)
BPCA Methylphenidate Genetic Toxicity Meeting
August 29, 2008
6100 Executive Boulevard, Rockville, MD
Meeting Minutes for Methylphenidate Genetic Toxicity Meeting April 2008 (PDF 851.88 kb)
BPCA EU-US Joint Research Initiative Meeting
July 8–9, 2008
6100 Executive Boulevard, Rockville, MD
Meeting Minutes for EU-US Joint Research Initiative Meeting July 2008 (PDF 1.54 mb)
Outcome Measures for Clinical Trials with Children with
Fragile X Syndrome
May 8–9, 2008
Hyatt Regency, Bethesda, MD
Meeting Minutes for Fragile X Syndrome May 2008 (PDF 1.31 mb)
top of page
2007
Adolescent Over-the-Counter (OTC) Drug Product Use:
A Public Workshop
December 6–7, 2007
Natcher Conference Center, National Institutes of Health, Bethesda, MD
Meeting Minutes for Adolescent Over-the-Counter (OTC) Drug Product Use December 207 (PDF 77 kb)
Pediatric Asthma Therapeutics Group Meeting
June 19, 2007
Conference Call
Meeting Minutes for Pediatric Asthma Therapeutics Group Meeting June 2007 (PDF 35 kb)
Pediatric Hypertension Treatment Working Group Meeting
May 30, 2007
Conference Call
Meeting Minutes for Pediatric Hypertension Treatment Working Group Meeting May 2007 (PDF 38 kb)
top of page
2006
2nd Annual Summer Institute in Maternal-Fetal Pharmacology
July 23–29, 2006
Wyndham Denver Tech Center, Denver, CO
Pediatric Hypertension Treatment Working Group Meeting
April 7, 2006
Marriott Bethesda North Hotel and Conference Center, Bethesda, MD
Meeting Minutes for Pediatric Hypertension Treatment Working Group Meeting April 2006 (PDF 162 kb)
NICHD Global Consortium on Pediatric Pharmacology Meeting
March 6, 2006
Hyatt Regency Baltimore, Baltimore, MD
Meeting Minutes for NICHD Global Consortium on Pediatric Pharmacology Meeting March 2006 (PDF 208 kb)
Emergency Research in Children: Ethical, Regulatory, and Clinical Challenges Workshop
January 12–13, 2006
Bethesda Marriott, Bethesda, MD
Meeting Minutes for Emergency Research in Children January 2006 (PDF 188 kb)
top of page
2005
Pediatric Formulation Initiative (PFI) Working Meeting
December 6–7, 2005
Bethesda Marriott, Bethesda, MD
Meeting Minutes for Pediatric Formulation Initiative (PFI) Working Meeting December 2005 (PDF 250 kb)
The goal of the Pediatric Formulation Initiative is for researchers and experts in pediatric formulation to meet to discuss issues and challenges that may stimulate further research in the field. The first phase of the PFI is currently under way with the formation of discussion groups. The following four groups have been created:
- Scientific, technical, and regulatory barriers for the development of pediatric formulations
- Taste, smell, and flavor research in infants and children
- Economic issues and partnerships
- Use and application in pediatrics of new drug delivery systems.
Pediatric Hypertension Treatment Working Group Meeting
June 17, 2005
Doubletree Rockville, Rockville, MD
Meeting Minutes for Pediatric Hypertension Treatment Working Group Meeting June 2005 (PDF 68 kb)
Improving Pediatric Therapeutics Through the Best Pharmaceuticals for Children Act of 2002
May 16, 2005
Grand Hyatt, Washington, DC
Meeting Minutes for Improving Pediatric Therapeutics May 2005 (PDF 1.71 MB)
top of page
2004
Extrapolation of Non-Clinical Models to Pediatric Clinical Studies: Setting the Research Agenda
October 28, 2004
Neuroscience Center, Rockville, MD
Meeting Minutes for Extrapolation of Non-Clinical Models to Pediatric Clinical Studies October 2004 (PDF 188 kb)
Newborn Drug Development Initiative Meeting
March 29–30, 2004
Baltimore Marriott Waterfront, Baltimore, MD
Meeting Minutes for Newborn Drug Development Initiative Meeting March 2004 (PDF 360 KB)
Meeting Minutes Appendices for Newborn Drug Development Initiative Meeting March 2004 (PDF 377 kb)
top of page